See Conatus Pharmaceuticals Inc. (CNAT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

11/18/2019 · Interactive chart for Conatus Pharmaceuticals Inc. (CNAT) – analyse all of the data with a huge range of indicators. Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue Estimates Conatus (CNAT) delivered earnings and revenue surprises of 16.67% and -48.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? 12/13/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investment decisions. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the 12/1/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investing decisions. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Las noticias, el correo electrónico y las búsquedas son tan solo el comienzo. Descubre algo nuevo todos los días en Yahoo.

Conatus Pharmaceuticals Inc. (CNAT) Add to watchlist. NasdaqCM - NasdaqCM Real-time price. Australian finance news, stock quotes, currency information and blogs.

9/29/2019 · See Conatus Pharmaceuticals Inc. (CNAT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 3/25/2014 · At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage 1/29/2019 · Gráfico interactivo para Conatus Pharmaceuticals Inc. (CNAT), analiza todos los datos con una enorme variedad de indicadores. 8/30/2019 · Find out the direct holders, institutional holders and mutual fund holders for Conatus Pharmaceuticals Inc. (CNAT). Obtén las últimas Conatus Pharmaceuticals Inc. (CNAT) noticias y encabezados de cotizaciones para ayudarte con tus decisiones de operaciones e inversiones. News, email and search are just the beginning. Discover more every day. Find your yodel.

View live CONATUS PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, CNAT financials and market news. Yahoo Finance · Nov 29 · Conatus Pharmaceuticals Appoints Kathy Scott as Independent 

CNAT | Complete Conatus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. 11/5/2019 · Find the latest Conatus Pharmaceuticals Inc. (CNAT) stock quote, history, news and other vital information to help you with your stock trading and investing. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. 11/18/2019 · Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board Member. SAN DIEGO, Nov. 18, 2019 -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional. Encuentra la cotización más reciente, historial, noticias y otra información vital de Conatus Pharmaceuticals Inc. (CNAT) para ayudarte con tus inversiones e 11/5/2019 · Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Conatus Pharmaceuticals Inc. (CNAT) para ayudarte con tus

Analyzing Conatus Pharmaceuticals (NASDAQ:CNAT) stock? View CNAT's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC 

12/13/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investment decisions. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the 12/1/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investing decisions. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

CNAT | Complete Conatus Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

11/18/2019 · Interactive chart for Conatus Pharmaceuticals Inc. (CNAT) – analyse all of the data with a huge range of indicators. Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue Estimates Conatus (CNAT) delivered earnings and revenue surprises of 16.67% and -48.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? 12/13/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investment decisions. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the 12/1/2019 · Get the latest Conatus Pharmaceuticals Inc. (CNAT) stock news and headlines to help you in your trading and investing decisions. Conatus Pharmaceuticals Inc. Common Stock (CNAT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

11/5/2019 · Consulta las últimas cotizaciones de acciones, historial, noticias y otra información vital de Conatus Pharmaceuticals Inc. (CNAT) para ayudarte con tus 12/24/2019 · Discover historical prices for CNAT stock on Yahoo Finance. View daily, weekly or monthly format back to when Conatus Pharmaceuticals Inc. stock was issued. Obtén las últimas Conatus Pharmaceuticals Inc. (CNAT) noticias y encabezados de cotizaciones para ayudarte con tus decisiones de operaciones e inversiones.